Reindorf C A, Walker-Jones D, Adekile A D, Lawal O, Oluwole S F
J Natl Med Assoc. 1989 Aug;81(8):866-8.
Chronic leg ulcers in sickle cell anemia occur mainly around the ankles. The prevalence is up to 75% in adults. These ulcers are painful and debilitating, yet medical treatment is unsuccessful. Surgical treatment consists of repeated skin grafting procedures, which eventually deplete the patient's available donor sites. Thus, in vitro generation of human epidermal autograft for potential treatment of leg ulcers in sickle cell anemia was initiated. However, because epidermal cells need a supporting matrix in order to be applied to the ulcer, the authors decided to assess the independent effect of a collagen matrix alone in promoting healing of sickle cell leg ulcers. Collistat (Hellistex, Inc) dressing was applied directly to the ulcers. The ulcers were reviewed every 2 weeks, and the dressing reapplied every 4 weeks. Collagen matrix caused the chronic ulcers to heal completely in fewer than 3 months. This encouraging performance of collagen alone should be greatly enhanced by the in vitro epidermal autograft.
镰状细胞贫血患者的慢性腿部溃疡主要发生在脚踝周围。在成年人中,患病率高达75%。这些溃疡疼痛且使人虚弱,但药物治疗效果不佳。手术治疗包括反复的皮肤移植手术,最终会耗尽患者可用的供皮区。因此,开始进行人表皮自体移植的体外培养,以潜在治疗镰状细胞贫血患者的腿部溃疡。然而,由于表皮细胞需要一种支撑基质才能应用于溃疡,作者决定评估单独的胶原蛋白基质在促进镰状细胞性腿部溃疡愈合方面的独立作用。将Collistat(Hellistex公司)敷料直接应用于溃疡。每2周对溃疡进行复查,每4周更换一次敷料。胶原蛋白基质使慢性溃疡在不到3个月的时间内完全愈合。单独使用胶原蛋白的这种令人鼓舞的效果,通过体外表皮自体移植应能得到极大增强。